GSA Capital Partners’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Sell |
36,882
-33,532
| -48% | -$271K | 0.02% | 1254 |
|
|
2025
Q1 | $590K | Sell |
70,414
-1,687
| -2% | -$14.1K | 0.05% | 677 |
|
|
2024
Q4 | $571K | Buy |
72,101
+17,751
| +33% | +$141K | 0.04% | 784 |
|
|
2024
Q3 | $452K | Sell |
54,350
-100,410
| -65% | -$835K | 0.03% | 972 |
|
|
2024
Q2 | $983K | Sell |
154,760
-28,202
| -15% | -$179K | 0.07% | 510 |
|
|
2024
Q1 | $1.11M | Buy |
+182,962
| New | +$1.11M | 0.09% | 375 |
|
|
2023
Q4 | – | Sell |
-22,986
| Closed | -$97K | – | 1470 |
|
|
2023
Q3 | $97K | Sell |
22,986
-91,265
| -80% | -$385K | 0.01% | 1390 |
|
|
2023
Q2 | $354K | Buy |
114,251
+33,732
| +42% | +$105K | 0.04% | 950 |
|
|
2023
Q1 | $112K | Sell |
80,519
-94,530
| -54% | -$131K | 0.01% | 1344 |
|
|
2022
Q4 | $348K | Buy |
+175,049
| New | +$348K | 0.04% | 834 |
|
|
2022
Q3 | – | Sell |
-151,865
| Closed | -$483K | – | 1483 |
|
|
2022
Q2 | $483K | Buy |
151,865
+43,891
| +41% | +$140K | 0.07% | 526 |
|
|
2022
Q1 | $450K | Buy |
107,974
+74,572
| +223% | +$311K | 0.06% | 608 |
|
|
2021
Q4 | $160K | Buy |
+33,402
| New | +$160K | 0.02% | 1262 |
|
|
2021
Q3 | – | Sell |
-111,200
| Closed | -$569K | – | 1396 |
|
|
2021
Q2 | $569K | Buy |
111,200
+86,333
| +347% | +$442K | 0.06% | 548 |
|
|
2021
Q1 | $167K | Sell |
24,867
-14,685
| -37% | -$98.6K | 0.03% | 942 |
|
|
2020
Q4 | $181K | Sell |
39,552
-14,312
| -27% | -$65.5K | 0.03% | 1019 |
|
|
2020
Q3 | $209K | Buy |
53,864
+3,963
| +8% | +$15.4K | 0.03% | 981 |
|
|
2020
Q2 | $238K | Sell |
49,901
-48,338
| -49% | -$231K | 0.13% | 261 |
|
|
2020
Q1 | $342K | Buy |
+98,239
| New | +$342K | 0.09% | 402 |
|
|
2019
Q3 | – | Sell |
-51,264
| Closed | -$368K | – | 1375 |
|
|
2019
Q2 | $368K | Buy |
+51,264
| New | +$368K | 0.04% | 860 |
|
|
2019
Q1 | – | Sell |
-17,343
| Closed | -$235K | – | 1400 |
|
|
2018
Q4 | $235K | Buy |
+17,343
| New | +$235K | 0.03% | 999 |
|